Nurix Therapeutics's total assets for Q3 2025 were $522.47M, a decrease of -11.68% from the previous quarter. NRIX total liabilities were $150.22M for the fiscal quarter, a 4.35% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.